dobutamine has been researched along with dihydropyridines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, MJ; Lanoce, V; Liang, BT; Manning, DR; Marzo, KP; Molinoff, PB; Wilson, JR | 1 |
| Budzinski, D; Goldberg, AD; Jafri, SM; Levine, TB; Pilla, A; Reddy, BR | 1 |
| Asai, K; Mathier, MA; Meguro, T; Sato, N; Shannon, RP; Shen, W; Uechi, M; Vatner, SF | 1 |
| Criniti, A; del Monte, F; Ducouret, P; Iwashiro, K; Monti, F; Papalia, U; Picard, S; Puddu, PE; Rouet, R; Ruvolo, G; Tonelli, E | 1 |
| Campa, PP; Criniti, A; Iwashiro, K; La Francesca, S; Marino, B; Monti, F; Papalia, U; Picard, S; Puddu, PE; Ruvolo, G | 1 |
| Allessie, M; Blaauw, Y; de Haan, S; Greiser, M; Harks, E; Schotten, U; van Hunnik, A; Verheule, S | 1 |
6 other study(ies) available for dobutamine and dihydropyridines
| Article | Year |
|---|---|
Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Catecholamines; Dihydropyridines; Dobutamine; Dogs; Electric Stimulation; GTP-Binding Proteins; Heart Failure; Heart Rate; Hemodynamics; Pertussis Toxin; Receptors, Adrenergic, beta; Virulence Factors, Bordetella | 1991 |
Acute neurohormonal and hemodynamic response to a new peak III phosphodiesterase inhibitor (ICI 153,110) in patients with chronic heart failure.
Topics: Dihydropyridines; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Norepinephrine; Phosphodiesterase Inhibitors; Pyridazines; Renin | 1990 |
Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure.
Topics: Animals; Calcium Channel Agonists; Calcium Channels; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Catecholamines; Dihydropyridines; Dobutamine; Dogs; Drug Resistance; Female; Heart Rate; Hemodynamics; Male; Myocardial Contraction; Oxygen Consumption; Ventricular Function, Left | 1998 |
Protection of human myocardium in vitro by K(ATP) activation with low concentrations of bimakalim.
Topics: Adenosine Triphosphate; Adult; Benzopyrans; Dihydropyridines; Dobutamine; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; Heart Atria; Humans; Hypoxia; In Vitro Techniques; Isometric Contraction; Muscle Contraction; Myocardial Contraction; Myocardium; Oxygen; Potassium Channels; Time Factors | 1999 |
Adenosine triphosphate-dependent potassium channel modulation and cardioplegia-induced protection of human atrial muscle in an in vitro model of myocardial stunning.
Topics: Adenosine Triphosphate; Adult; Aged; Atrial Function, Right; Benzopyrans; Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Cardiotonic Agents; Cell Hypoxia; Dihydropyridines; Dobutamine; Female; Glyburide; Heart Arrest, Induced; Humans; In Vitro Techniques; Magnesium; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Sodium Chloride | 2000 |
AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat.
Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Function, Right; Biphenyl Compounds; Cardiotonic Agents; Delayed Rectifier Potassium Channels; Digoxin; Dihydropyridines; Disease Models, Animal; Dobutamine; Electric Countershock; Electrocardiography; Goats; Myocardial Contraction; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Quinolines; Thiadiazines | 2006 |